The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Data transparency and demographic representation in approval packages of FDA-approved oncology drugs from 2012-2021.
 
Jingyi Liu
Stock and Other Ownership Interests - Augment Biologics; Bridgebio; Intellia Therapeutics; Lilly O.; Silence Therapeutics
Consulting or Advisory Role - Augment Biologics
 
Gowri Jayaram
Employment - Medidata Acorn AI; Medidata Acorn AI
Stock and Other Ownership Interests - Medidata Acorn AI
Travel, Accommodations, Expenses - Medidata Acorn AI
 
Tanvee Varma
No Relationships to Disclose
 
Stephen Sammut
No Relationships to Disclose
 
Carmen Guerra
Leadership - Freenome; GlaxoSmithKline; GRAIL; Guardant Health
Stock and Other Ownership Interests - BEAM Therapeutics; crispr therapeutics; Editas Medicine; Intellia Therapeutics
Consulting or Advisory Role - AstraZeneca (I)
Speakers' Bureau - Esperion Therapeutics (I); Janssen (I)
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Esperion Therapeutics (I)
 
Jennifer E. Miller
No Relationships to Disclose